The Impact of Comorbidities and Organ Dysfunction Commonly Used for Clinical Trial Eligibility Criteria on Outcome in Acute Myeloid Leukemia (AML) Patients Receiving Induction Chemotherapy

被引：1
|
作者：
Statler, Abby [1 ]
Hobbs, Brian P. [2 ]
Radivoyevitch, Tomas [3 ]
Siebenaller, Caitlin [4 ]
Mukherjee, Sudipto [5 ]
Advani, Anjali S. [5 ]
Gerds, Aaron T. [5 ]
Nazha, Aziz [5 ]
Patel, Bhumika J. [5 ]
Carraway, Hetty E. [5 ]
Sekeres, Mikkael A. [5 ]
机构：
[1] Cleveland Clin, Canc Biostat, Shaker Hts, OH USA
[2] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH USA
[3] Quantitat Hlth Sci, Dept Quantitat Hlth Sci & Translat Hematol & Onco, Cleveland, OH USA
[4] Cleveland Clin Taussig Canc Inst, Leuekmia Program, Cleveland, OH USA
[5] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Leukemia Program, Cleveland, OH USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-130319
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
16
引用
收藏
页数：4
相关论文
共 50 条
  • [41] The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML
    Kayser, Sabine
    Doehner, Konstanze
    Krauter, Juergen
    Koehne, Claus-Henning
    Horst, Heinz A.
    Held, Gerhard
    von Lilienfeld-Toal, Marie
    Wilhelm, Sibylla
    Kuendgen, Andrea
    Goetze, Katharina
    Rummel, Mathias
    Nachbaur, David
    Schlegelberger, Brigitte
    Goehring, Gudrun
    Spaeth, Daniela
    Morlok, Carina
    Zucknick, Manuela
    Ganser, Arnold
    Doehner, Hartmut
    Schlenk, Richard F.
    BLOOD, 2011, 117 (07) : 2137 - 2145
  • [42] Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation
    Juliane Grimm
    Marius Bill
    Madlen Jentzsch
    Stefanie Beinicke
    Janine Häntschel
    Karoline Goldmann
    Julia Schulz
    Michael Cross
    Georg–Nikolaus Franke
    Gerhard Behre
    Vladan Vucinic
    Wolfram Pönisch
    Thoralf Lange
    Dietger Niederwieser
    Sebastian Schwind
    Bone Marrow Transplantation, 2019, 54 : 1189 - 1197
  • [43] Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation
    Grimm, Juliane
    Bill, Marius
    Jentzsch, Madlen
    Beinicke, Stefanie
    Haentschel, Janine
    Goldmann, Karoline
    Schulz, Julia
    Cross, Michael
    Franke, Georg-Nikolaus
    Behre, Gerhard
    Vucinic, Vladan
    Poenisch, Wolfram
    Lange, Thoralf
    Niederwieser, Dietger
    Schwind, Sebastian
    BONE MARROW TRANSPLANTATION, 2019, 54 (08) : 1189 - 1197
  • [44] Characteristics and Outcome of Patients with Acute Myeloid Leukemia (AML) Refractory to One Cycle of High Dose Cytarabine-Based Induction Chemotherapy.
    Ravandi, Farhad
    Cortes, Jorge
    Faderl, Stefan
    O'Brien, Susan
    Garcia-Manero, Guillermo
    Verstovsek, Srdan
    de Lima, Marcos
    Pierce, Sherry
    Brandt, Mark
    Borthakur, Gautam
    Ferrajoli, Alessandra
    Wierda, William G.
    Koller, Charles A.
    Kantarjian, Hagop M.
    BLOOD, 2009, 114 (22) : 430 - 430
  • [45] Induction chemotherapy with high-dose cytarabine and mitoxantrone in elderly acute myeloid leukemia (AML) patients.
    Ramanathan, Muthalagu
    Cerny, Jan
    Raffel, Glen
    Walsh, William Vincent
    Woda, Bruce
    Miron, Patricia
    Nath, Rajneesh
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [46] THE EFFECTIVENESS OF PLATELETS TRANSFUSIONS IN PATIENTS WITH DE NOVO ACUTE MYELOID LEUKEMIA (AML) DURING INDUCTION CHEMOTHERAPY (IC).
    Davaasambuu, B.
    Gritsaev, S.
    HAEMATOLOGICA, 2013, 98 : 193 - 193
  • [47] Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy
    Areej El-Jawahri
    Gregory A. Abel
    Lara Traeger
    Lauren Waldman
    Netana Markovitz
    Harry VanDusen
    Amir Fathi
    David P. Steensma
    Thomas W. LeBlanc
    Nora K. Horick
    Daniel J. DeAngelo
    Martha Wadleigh
    Gabriela Hobbs
    Julia Foster
    Andrew M. Brunner
    Philip Amrein
    Richard M. Stone
    Jennifer S. Temel
    Joseph A. Greer
    Leukemia, 2019, 33 : 2393 - 2402
  • [48] Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy:: Causes and consequences
    Hamalainen, Sari
    Kuittinen, Taru
    Marinlauri, Irma
    Nousiainen, Tapio
    Koivula, Irma
    Jantunen, Esa
    LEUKEMIA & LYMPHOMA, 2008, 49 (03) : 495 - 501
  • [49] Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy
    El-Jawahri, Areej
    Abel, Gregory A.
    Traeger, Lara
    Waldman, Lauren
    Markovitz, Netana
    VanDusen, Harry
    Fathi, Amir
    Steensma, David P.
    LeBlanc, Thomas W.
    Horick, Nora K.
    DeAngelo, Daniel J.
    Wadleigh, Martha
    Hobbs, Gabriela
    Foster, Julia
    Brunner, Andrew M.
    Amrein, Philip
    Stone, Richard M.
    Temel, Jennifer S.
    Greer, Joseph A.
    LEUKEMIA, 2019, 33 (10) : 2393 - 2402
  • [50] Outcomes in Obese and Overweight Acute Myeloid Leukemia (AML) Patients Receiving Chemotherapy Dosed According to Actual Body Weight
    Gallagher, Erika M.
    Earl, Marc
    Yeh, Jun-Yen
    Kusick, Karissa
    Kruse, Jaclyn
    Swann, Caitlin
    Smith, April
    Davis, Randall
    Advani, Anjali S.
    Kalaycio, Matt
    Copelan, Edward A.
    Sekeres, Mikkael A.
    BLOOD, 2011, 118 (21) : 649 - 649
12345